\-\ Texto\\:\\ \ \(0\)\
\-\ abdominal\\ mass\\ noted\\ on\\ well\\-child\\ exam\\.\ \(0\)\
\-\ monitor\\ \\‚\\Ä\\ì\\ early\\ detection\\ vital\\!\ \(0\)\
\-\ baseline\\ ct\\ at\\ diagnosis\ \(0\)\
\-\ us\\/mr\\ alternating\\ every\\ 3\\-4\\ months\\ until\\ age\\ 7\ \(0\)\
\-\ \\(based\\ on\\ national\\ wilms\\‚\\Ä\\ô\\ tumor\\ studies\\ \\‚\\Ä\\ì\\ 6\\ month\\ time\\ frame\\ for\\ met\\ development\\)\ \(0\)\
\-\ r\\/o\\ associated\\ syndromes\\ \\(beckwidth\\-wiedemann\\,\\ wagr\\ etc\\.\\)\ \(0\)\
\-\ most\\ will\\ spontaneously\\ resolve\\ but\\ enlargement\\ suggests\\ degeneration\\ to\\ wilms\\ tumor\ \(0\)\
\-\ us\\:\\ diffusely\\ enlarged\\,\\ lobulated\\ contour\\ and\\ hypoechoic\\ cortical\\ masses\ \(0\)\
\-\ ct\\:\\ diffuse\\ enlargement\\,\\ multiple\\ round\\ masses\\ of\\ low\\ attenuation\\,\\ symmetry\\,\\ compressed\\ central\\ enhancing\\ kidney\\ parenchyma\ \(0\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ wilms\\ tumor\ \(0\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ 16\\ month\\-old\\ asymptomatic\\ female\\ reaching\\ normal\\ developmental\\ milestones\\ without\\ significant\\ pmh\\.\ \(0\)\
\-\ multiple\\ foci\\ of\\ \\‚\\Ä\\únephrogenic\\ rests\\‚\\Ä\\ù\\ \\(embryonic\\ tissue\\ persistence\\)\ \(0\)\
\-\ risk\\ for\\ malignant\\ transformation\\ \\(wilms\\ tumor\\)\ \(0\)\
\-\ genetic\\ link\\ \\ \ \(0\)\
\-\ types\\:\ \(11\)\
\-\ 1\\.\\ intralobar\\ \\‚\\Ä\\ì\\ random\\,\\ less\\ common\\ than\\ perilobar\\,\\ higher\\ risk\\ or\\ malignant\\ transformation\\,\\ associated\\ with\\ wagr\\,\\ drash\\ syndrome\\,\\ sporadic\\ aniridia\\ \\(30\\%\\ progress\\ to\\ wilms\\)\\ \ \(0\)\
\-\ 2\\.\\ perilobar\\ \\‚\\Ä\\ì\\ multiple\\ at\\ cortio\\-medullary\\ jxn\\ or\\ cortex\\,\\ associated\\ with\\ beckwith\\-wiedemann\\ \\(5\\%\\ progress\\ to\\ wilms\\)\\,\\ hemihypertrophy\\,\\ \\ perlman\\ syndrome\\,\\ trisomy\\ 18\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wilms\\:\\ 0\\.1644297792544146\ \(0\)\
\-\ wagr\\:\\ 0\\.09135252252815025\ \(0\)\
\-\ perilobar\\:\\ 0\\.08416965019074149\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.07970373314798959\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.06980390551592396\ \(0\)\
\-\ transformation\\:\\ 0\\.05020960114419044\ \(0\)\
\-\ progress\\:\\ 0\\.05001590028396087\ \(0\)\
\-\ well\\-child\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ us\\/mr\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ beckwidth\\-wiedemann\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ \\-risk\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ \\-genetic\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ \\-types\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ drash\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ cortio\\-medullary\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ jxn\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ perlman\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ tumor\\:\\ 0\\.04128978863442096\ \(0\)\
\-\ aniridia\\:\\ 0\\.039983969612945015\ \(0\)\
\-\ beckwith\\-wiedemann\\:\\ 0\\.039983969612945015\ \(0\)\
\-\ hemihypertrophy\\:\\ 0\\.039983969612945015\ \(0\)\
\-\ enlargement\\:\\ 0\\.035135423901399954\ \(0\)\
\-\ symmetry\\:\\ 0\\.03490195275796198\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.03490195275796198\ \(0\)\
\-\ frame\\:\\ 0\\.03429167796181491\ \(0\)\
\-\ \\-multiple\\:\\ 0\\.03429167796181491\ \(0\)\
\-\ embryonic\\:\\ 0\\.03374576855426141\ \(0\)\
\-\ milestones\\:\\ 0\\.03325193342574159\ \(0\)\
\-\ rests\\:\\ 0\\.032801097275536255\ \(0\)\
\-\ intralobar\\:\\ 0\\.032801097275536255\ \(0\)\
\-\ random\\:\\ 0\\.032801097275536255\ \(0\)\
\-\ malignant\\:\\ 0\\.032006950014293274\ \(0\)\
\-\ month\\-old\\:\\ 0\\.0320023890899028\ \(0\)\
\-\ trisomy\\:\\ 0\\.03164491307183569\ \(0\)\
\-\ associated\\:\\ 0\\.03134397764623371\ \(0\)\
\-\ national\\:\\ 0\\.0313105165892576\ \(0\)\
\-\ alternating\\:\\ 0\\.030996399377773484\ \(0\)\
\-\ met\\:\\ 0\\.030996399377773484\ \(0\)\
\-\ reaching\\:\\ 0\\.030996399377773484\ \(0\)\
\-\ masses\\:\\ 0\\.029933599979234067\ \(0\)\
\-\ \\!\\:\\ 0\\.029660497257037215\ \(0\)\
\-\ persistence\\:\\ 0\\.029430177243716833\ \(0\)\
\-\ link\\:\\ 0\\.02879493205152858\ \(0\)\
\-\ sporadic\\:\\ 0\\.028599386310684816\ \(0\)\
\-\ r\\/o\\:\\ 0\\.027254768717497848\ \(0\)\
\-\ compressed\\:\\ 0\\.026966842027576546\ \(0\)\
\-\ baseline\\:\\ 0\\.026188177763072206\ \(0\)\
\-\ resolve\\:\\ 0\\.026188177763072206\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.02595262142070559\ \(0\)\
\-\ detection\\:\\ 0\\.025727309959877927\ \(0\)\
\-\ syndrome\\:\\ 0\\.025325456753726855\ \(0\)\
\-\ syndromes\\:\\ 0\\.02530410772664338\ \(0\)\
\-\ monitor\\:\\ 0\\.0252034958828242\ \(0\)\
\-\ spontaneously\\:\\ 0\\.025007950141980435\ \(0\)\
\-\ etc\\:\\ 0\\.023968205605907112\ \(0\)\
\-\ every\\:\\ 0\\.023517369455701778\ \(0\)\
\-\ degeneration\\:\\ 0\\.022477624919628455\ \(0\)\
\-\ \\(\\:\\ 0\\.022456841230379082\ \(0\)\
\-\ diffusely\\:\\ 0\\.02236118525200121\ \(0\)\
\-\ lobulated\\:\\ 0\\.022247304906308073\ \(0\)\
\-\ \\)\\:\\ 0\\.022182518925802232\ \(0\)\
\-\ suggests\\:\\ 0\\.022135873791173547\ \(0\)\
\-\ pmh\\:\\ 0\\.02202678876942312\ \(0\)\
\-\ higher\\:\\ 0\\.021712671557939\ \(0\)\
\-\ contour\\:\\ 0\\.021464712898987524\ \(0\)\
\-\ vital\\:\\ 0\\.021182023861420506\ \(0\)\
\-\ \\%\\:\\ 0\\.020656176511357593\ \(0\)\
\-\ developmental\\:\\ 0\\.020576846308331127\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.0201841321147066\ \(0\)\
\-\ 16\\:\\ 0\\.020035018308747824\ \(0\)\
\-\ \\,\\:\\ 0\\.019636999571202192\ \(0\)\
\-\ until\\:\\ 0\\.019445198916785138\ \(0\)\
\-\ development\\:\\ 0\\.01928377317699345\ \(0\)\
\-\ 18\\:\\ 0\\.019220585233502164\ \(0\)\
\-\ round\\:\\ 0\\.019127225101363932\ \(0\)\
\-\ foci\\:\\ 0\\.019005305425663446\ \(0\)\
\-\ cortex\\:\\ 0\\.018945404791460983\ \(0\)\
\-\ parenchyma\\:\\ 0\\.018856832597889478\ \(0\)\
\-\ multiple\\:\\ 0\\.018650839414292943\ \(0\)\
\-\ us\\:\\ 0\\.018572071539439957\ \(0\)\
\-\ attenuation\\:\\ 0\\.01780114544262196\ \(0\)\
\-\ \\:\\:\\ 0\\.017569038590528472\ \(0\)\
\-\ 30\\:\\ 0\\.017026369618938213\ \(0\)\
\-\ 7\\:\\ 0\\.016965051185534052\ \(0\)\
\-\ based\\:\\ 0\\.016884406022108604\ \(0\)\
\-\ studies\\:\\ 0\\.01653627418538425\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.01653627418538425\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.016443582140043444\ \(0\)\
\-\ early\\:\\ 0\\.01619253352146341\ \(0\)\
\-\ cortical\\:\\ 0\\.016140284199874674\ \(0\)\
\-\ risk\\:\\ 0\\.016037340141756926\ \(0\)\
\-\ kidney\\:\\ 0\\.015597841736010414\ \(0\)\
\-\ enlarged\\:\\ 0\\.015106844924269464\ \(0\)\
\-\ less\\:\\ 0\\.014994507794418044\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.014966799989617034\ \(0\)\
\-\ central\\:\\ 0\\.014568038118445384\ \(0\)\
\-\ 2\\.\\:\\ 0\\.014080021460104964\ \(0\)\
\-\ enhancing\\:\\ 0\\.013885769600439168\ \(0\)\
\-\ will\\:\\ 0\\.013852233255850476\ \(0\)\
\-\ 1\\.\\:\\ 0\\.01382999568029845\ \(0\)\
\-\ age\\:\\ 0\\.013476219303338376\ \(0\)\
\-\ diffuse\\:\\ 0\\.0134041835252607\ \(0\)\
\-\ month\\:\\ 0\\.013282976895339946\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.01323329916914744\ \(0\)\
\-\ 6\\:\\ 0\\.013223420525258416\ \(0\)\
\-\ 5\\:\\ 0\\.012954199080021572\ \(0\)\
\-\ time\\:\\ 0\\.0125057058406182\ \(0\)\
\-\ ct\\:\\ 0\\.012386566356394228\ \(0\)\
\-\ low\\:\\ 0\\.012311751569255956\ \(0\)\
\-\ months\\:\\ 0\\.012092960076114339\ \(0\)\
\-\ at\\:\\ 0\\.01199754562519827\ \(0\)\
\-\ significant\\:\\ 0\\.011905943787845718\ \(0\)\
\-\ than\\:\\ 0\\.011601289403721626\ \(0\)\
\-\ common\\:\\ 0\\.011586876745888068\ \(0\)\
\-\ abdominal\\:\\ 0\\.011066939057627541\ \(0\)\
\-\ noted\\:\\ 0\\.01049441030286318\ \(0\)\
\-\ tissue\\:\\ 0\\.01049441030286318\ \(0\)\
\-\ without\\:\\ 0\\.010424938685793576\ \(0\)\
\-\ or\\:\\ 0\\.010378474082525468\ \(0\)\
\-\ most\\:\\ 0\\.01022194373952371\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010166939537722384\ \(0\)\
\-\ exam\\:\\ 0\\.00972660072512714\ \(0\)\
\-\ but\\:\\ 0\\.009443022285147864\ \(0\)\
\-\ female\\:\\ 0\\.009102384826154579\ \(0\)\
\-\ for\\:\\ 0\\.007555524856401193\ \(0\)\
\-\ on\\:\\ 0\\.007501461268035524\ \(0\)\
\-\ normal\\:\\ 0\\.006940997174088606\ \(0\)\
\-\ to\\:\\ 0\\.0066383643799427915\ \(0\)\
\-\ mass\\:\\ 0\\.006157829051541786\ \(0\)\
\-\ with\\:\\ 0\\.0012124785087035206\ \(0\)\
\-\ of\\:\\ 0\\.0012072932725180148\ \(0\)\
\-\ and\\:\\ 0\\.0009326891488715982\ \(0\)\
\-\ \\.\\:\\ 0\\.000551806260580512\ \(0\)\
